Mu Li
Papers
1
Total Citations
20
H-Index
1
About
Mu Li is a pioneering surgeon-researcher at the forefront of robotic-assisted urologic surgery, with a particular focus on advancing minimally invasive techniques for prostate cancer treatment. His most impactful work centers on the comparative evaluation of surgical robotic systems, most notably through a landmark prospective, double-center, randomized controlled trial that directly compared the KangDuo surgical system—a domestically developed Chinese robotic platform—against the established da Vinci Si system for robot-assisted radical prostatectomy. This study, published in 2024 and already garnering 20 citations, provides critical evidence on the efficacy, safety, and potential cost-effectiveness of emerging robotic technologies, addressing a pressing global need for more accessible surgical options. Beyond this, Li’s research contributions extend to refining surgical protocols and optimizing patient outcomes in urologic oncology. His work not only demonstrates the viability of alternative robotic platforms but also sets a rigorous standard for clinical trials in surgical innovation. With a growing citation footprint, Mu Li is shaping the future of robotic surgery, making high-quality care more attainable worldwide.
Research Focus
Key Achievements
Top Papers
- 1